{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:37:06Z","timestamp":1773769026384,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110722","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T03:59:41Z","timestamp":1691726381000},"page":"110722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors"],"prefix":"10.1016","volume":"123","author":[{"given":"Jiage","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"70","key":"10.1016\/j.intimp.2023.110722_b0005","doi-asserted-by":"crossref","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci. Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110722_b0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trsl.2015.07.008","article-title":"Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives","volume":"168","author":"Constantino","year":"2016","journal-title":"Transl. Res"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nprot.2017.130","article-title":"Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents","volume":"13","author":"Obermajer","year":"2018","journal-title":"Nat. Protoc"},{"issue":"5","key":"10.1016\/j.intimp.2023.110722_b0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther"},{"issue":"13","key":"10.1016\/j.intimp.2023.110722_b0035","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","article-title":"An Oncolytic Virus Expressing IL15\/IL15Ralpha Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer. Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0040","doi-asserted-by":"crossref","first-page":"2118210","DOI":"10.1080\/2162402X.2022.2118210","article-title":"CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy","volume":"11","author":"Li","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0045","doi-asserted-by":"crossref","first-page":"2096572","DOI":"10.1080\/2162402X.2022.2096572","article-title":"Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression","volume":"11","author":"Kudling","year":"2022","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110722_b0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80614-7","article-title":"IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production","volume":"9","author":"Grohmann","year":"1998","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2023.110722_b0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00262-015-1655-y","article-title":"Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells","volume":"64","author":"Rubinstein","year":"2015","journal-title":"Cancer. Immunol. Immunother"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0060","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-020-19781-y","article-title":"Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma","volume":"11","author":"Melaiu","year":"2020","journal-title":"Nat. Commun"},{"key":"10.1016\/j.intimp.2023.110722_b0065","doi-asserted-by":"crossref","first-page":"1040600","DOI":"10.3389\/fimmu.2022.1040600","article-title":"Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients","volume":"13","author":"Sosa Cuevas","year":"2022","journal-title":"Front. Immunol"},{"issue":"13","key":"10.1016\/j.intimp.2023.110722_b0070","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/cancers13133375","article-title":"Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma","volume":"13","author":"Vogt","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2023.110722_b0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41423-019-0250-0","article-title":"Notch ligand-expressing adenovirus infection enhances the efficacy of dendritic cell-based immunotherapy for allergic asthma in mice","volume":"16","author":"Lin","year":"2019","journal-title":"Cell. Mol. Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2023.110722_b0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-018-2144-x","article-title":"CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8(+) T cells to Tc1 phenotype","volume":"67","author":"Dharmadhikari","year":"2018","journal-title":"Cancer. Immunol. Immunother"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1566523053544272","article-title":"Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer","volume":"5","author":"Wu","year":"2005","journal-title":"Curr. Gene. Ther"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40425-019-0552-x","article-title":"Multiple antigen-engineered DC vaccines with or without IFNalpha to promote antitumor immunity in melanoma","volume":"7","author":"Butterfield","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2023.110722_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2021.11.017","article-title":"Dual-targeting vaccine of FGL1\/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity","volume":"24","author":"Chai","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1535-7163.MCT-18-0832","article-title":"Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8(+) T-cell Responses","volume":"18","author":"Chai","year":"2019","journal-title":"Mol. Cancer. Ther"},{"key":"10.1016\/j.intimp.2023.110722_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106034","article-title":"Adenovirus vaccine therapy with CD137L promotes CD8(+) DCs-mediated multifunctional CD8(+) T cell immunity and elicits potent anti-tumor activity","volume":"175","author":"Ding","year":"2022","journal-title":"Pharmacol. Res"},{"key":"10.1016\/j.intimp.2023.110722_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.omto.2021.11.018","article-title":"Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma","volume":"24","author":"Zhang","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0115","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/s41467-019-13368-y","article-title":"Engineering dendritic cell vaccines to improve cancer immunotherapy","volume":"10","author":"Perez","year":"2019","journal-title":"Nat. Commun"},{"issue":"22","key":"10.1016\/j.intimp.2023.110722_b0120","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.02538-14","article-title":"Adenovirus E1A targets the DREF nuclear factor to regulate virus gene expression, DNA replication, and growth","volume":"88","author":"Radko","year":"2014","journal-title":"J. Virol"},{"issue":"21","key":"10.1016\/j.intimp.2023.110722_b0125","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1158\/1078-0432.CCR-21-4384","article-title":"Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma","volume":"28","author":"Meister","year":"2022","journal-title":"Clin. Cancer. Res"},{"key":"10.1016\/j.intimp.2023.110722_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2017.02.012","article-title":"Understanding memory CD8(+) T cells","volume":"185","author":"Samji","year":"2017","journal-title":"Immunol. Lett"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.intimp.2023.110722_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2019.12.019","article-title":"Combining epigenetic and immune therapy to overcome cancer resistance","volume":"65","author":"Gomez","year":"2020","journal-title":"Semin. Cancer. Biol"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110722_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41434-018-0044-5","article-title":"Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy","volume":"26","author":"Mukhopadhyay","year":"2019","journal-title":"Gene. Ther"},{"key":"10.1016\/j.intimp.2023.110722_b0150","doi-asserted-by":"crossref","unstructured":"C.S. Garris, S.P. Arlauckas, R.H. Kohler, M.P. Trefny, S. Garren, C. Piot, C. Engblom, C. Pfirschke, M. Siwicki, J. Gungabeesoon, G.J. Freeman, S.E. Warren, S. Ong, E. Browning, C.G. Twitty, R.H. Pierce, M.H. Le, A.P. Algazi, A.I. Daud, S.I. Pai, A. Zippelius, R. Weissleder, M.J. Pittet, Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12, Immunity 49(6) (2018) 1148-1161 e7.","DOI":"10.1016\/j.immuni.2018.09.024"},{"issue":"8","key":"10.1016\/j.intimp.2023.110722_b0155","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther"},{"issue":"17","key":"10.1016\/j.intimp.2023.110722_b0160","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/1078-0432.CCR-13-1185","article-title":"A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside","volume":"19","author":"Chiang","year":"2013","journal-title":"Clin. Cancer. Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12967-019-02133-w","article-title":"A Phase I\/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma","volume":"17","author":"Sarivalasis","year":"2019","journal-title":"J. Transl. Med"},{"issue":"7607","key":"10.1016\/j.intimp.2023.110722_b0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.110722_b0175","doi-asserted-by":"crossref","first-page":"21570","DOI":"10.1038\/s41598-022-25065-w","article-title":"Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model","volume":"12","author":"Abdelmoneim","year":"2022","journal-title":"Sci. Rep"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cgt.2012.95","article-title":"Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers","volume":"20","author":"Choi","year":"2013","journal-title":"Cancer. Gene. Ther"},{"issue":"2","key":"10.1016\/j.intimp.2023.110722_b0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2023.110722_b0190","first-page":"138","article-title":"Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies","volume":"38","author":"Zhu","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol"},{"issue":"39","key":"10.1016\/j.intimp.2023.110722_b0195","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.intimp.2023.110722_b0200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2023.110722_b0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:32:09Z","timestamp":1736433129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923010470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S1567576923010470"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110722","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110722"}}